ClinicalTrials.Veeva

Menu

Premedication and Haemodynamics After Spinal Anesthesia

M

Medical University of Gdansk

Status

Completed

Conditions

Hemodynamics After Spinal Anesthesia

Treatments

Drug: Midazolam
Drug: Morphine hydrochloride; Midazolam

Study type

Interventional

Funder types

Other

Identifiers

NCT01066247
GUMed-Ow-001

Details and patient eligibility

About

Blood pressure drop following spinal anesthesia is connected with sympathetic/parasympathetic activity which may be determinated by Heart Rate Variability (HRV) assessment. Sympathetic predomination expressed as LF/HF ratio above 2.5 is strongly connected with deeper blood pressure fall. As drugs given for premedication may have impact on HRV variables, the investigators would like to determine if pharmacological premedication may modify hemodynamic changes following spinal blockade. Two drugs will be compared - midazolam which is known to lead to increase in LF/HF ratio and morphine - opioid which provokes opposite effect.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • spinal blockade for elective surgery

Exclusion criteria

  • contraindications for spinal anesthesia
  • hypertension
  • heart failure
  • chronic respiratory failure
  • hypersensitivity for midazolam or morphine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Midazolam
Active Comparator group
Description:
intramuscular midazolam 15 mg given 30 minutes before spinal blockade performing
Treatment:
Drug: Midazolam
Morphine
Active Comparator group
Description:
intramuscular morphine 10 mg given 30 minutes before spinal blockade performing
Treatment:
Drug: Morphine hydrochloride; Midazolam

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems